Treat & Extend in ME secondary to CRVO
In the CENTERA study, significant functional and anatomic improvements were
Anti-VEGF therapies for AMD: where are we now?
Where are we now with the spread of these therapies for AMD to prevent blindness?
The Debate on Fluid Tolerance
What do the studies show? What do the experts think?
What is on the Horizon? A Symposium on the future of ophthalmology at Euretina 2021
Home monitoring, intravitreal treatments, gene therapy, AI. The future of ophthalmology through the
Euretina 2021 Virtual Congress
A video journey in the “new normal” of retina practices
Timely detection of wet AMD with remote home screening
Data from a retrospective real world study highlights low incidence of proactive treatment of nAMD
Remote monitoring in the management of retinal disease
a panel of top-tier international vitreoretinal surgeons
The experience shared by this group of professionals is aligned with their mission to promote and provide best practice recommendations
Only modern and best equipment advanced medical technologies and innovative diagnosis and treatment methods and technology.
Our organization has received a financial education grant from Bayer. Bayer has had no influence on this website content.